retatrutide mechanism retatrutide clinical trials 2024 2025 trial results press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – A review of an investigational
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

























